Compare Nutanix Inc (NTNX) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Vaxcyte Inc. Common Stock — how do they compare? Nutanix Inc trades at $69.61 (market cap $19.72B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Nutanix Inc is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is more actively traded (2,644,694 versus 2,236,075). Which is the better fit depends on your goals — on Pluang, investors hold Nutanix Inc for 17 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| NTNX | PCVX | |
|---|---|---|
Market Cap | $19.72B | $10.51B |
Volume | 2,236,075 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $74.63 | $73.82 |
52-Week Low | $34.41 | $40.32 |
Typical Hold Time | 17 Days | 0 Days |
Enterprise Value | $18.88B | $9.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutanix (NTNX) trades at $72.88, down 1.7% on the day but maintains strong technical momentum with bullish moving averages and positive analyst sentiment. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $0.60 beating expectations of $0.49, and impressive 86.8% gross margins. Recent Gartner Magic Quadrant recognitions highlight competitive strength in virtualization and container management platforms.
Outlook remains positive with 62.5% analyst buy ratings and $76.11 consensus price target, though elevated P/E of 14.1 and negative ROE of -395.76% warrant caution. Key risks include supply chain pressures and competitive IT services market, while AI growth initiatives and external storage expansion present upside potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
